Literature DB >> 22012633

Epidemiology of brain metastases.

Lakshmi Nayak1, Eudocia Quant Lee, Patrick Y Wen.   

Abstract

Brain metastases are one of the most common neurologic complications of cancer. The incidence is 9%-17% based on various studies, although the exact incidence is thought to be higher. The incidence is increasing with the availability of improved imaging techniques which aid early diagnosis, and effective systemic treatment regimens which prolong life, thus allowing cancer to disseminate to the brain. Lung cancer, breast cancer, and melanoma are the most frequent to develop brain metastases, and account for 67%-80% of all cancers. Most patients with brain metastases have synchronous extracerebral metastases. Some patients present with no known primary cancer diagnosis. In children, brain metastases are rare; germ cell tumors, sarcomas, and neuroblastoma are the common offenders.

Entities:  

Mesh:

Year:  2012        PMID: 22012633     DOI: 10.1007/s11912-011-0203-y

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN: 1523-3790            Impact factor:   5.075


  66 in total

1.  Prognostic factors of postrecurrence survival in completely resected stage I non-small cell lung cancer with distant metastasis.

Authors:  Jung-Jyh Hung; Wen-Juei Jeng; Wen-Hu Hsu; Kou-Juey Wu; Teh-Ying Chou; Chih-Cheng Hsieh; Min-Hsiung Huang; Jung-Sen Liu; Yu-Chung Wu
Journal:  Thorax       Date:  2010-03       Impact factor: 9.139

2.  2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial.

Authors:  Ian Smith; Marion Procter; Richard D Gelber; Sébastien Guillaume; Andrea Feyereislova; Mitch Dowsett; Aron Goldhirsch; Michael Untch; Gabriella Mariani; Jose Baselga; Manfred Kaufmann; David Cameron; Richard Bell; Jonas Bergh; Robert Coleman; Andrew Wardley; Nadia Harbeck; Roberto I Lopez; Peter Mallmann; Karen Gelmon; Nicholas Wilcken; Erik Wist; Pedro Sánchez Rovira; Martine J Piccart-Gebhart
Journal:  Lancet       Date:  2007-01-06       Impact factor: 79.321

3.  Late recurrence of renal cell carcinoma: retrospective and collaborative study of the Japanese Society of Renal Cancer.

Authors:  Noriomi Miyao; Seiji Naito; Seiichiro Ozono; Nobuo Shinohara; Naoya Masumori; Tatsuo Igarashi; Masahiro Nakao; Tomoyasu Tsushima; Yutaka Senga; Shigeo Horie; Hiro-omi Kanayama; Noriaki Tokuda; Mikio Kobayashi
Journal:  Urology       Date:  2010-10-23       Impact factor: 2.649

4.  Brain metastases from unknown primary tumour: a prospective study.

Authors:  R Rudà; M Borgognone; F Benech; E Vasario; R Soffietti
Journal:  J Neurol       Date:  2001-05       Impact factor: 4.849

5.  Cerebral metastases as first symptom of cancer: a clinico-pathologic study.

Authors:  M T Giordana; S Cordera; A Boghi
Journal:  J Neurooncol       Date:  2000-12       Impact factor: 4.130

6.  Surgical treatment of brain metastases from melanoma: a retrospective study of 91 patients.

Authors:  M Wroński; E Arbit
Journal:  J Neurosurg       Date:  2000-07       Impact factor: 5.115

Review 7.  Hematogenous brain metastasis in children.

Authors:  Richard G Curless; Stuart R Toledano; John Ragheb; William W Cleveland; Steven Falcone
Journal:  Pediatr Neurol       Date:  2002-03       Impact factor: 3.372

8.  Identifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG).

Authors:  B C Pestalozzi; D Zahrieh; K N Price; S B Holmberg; J Lindtner; J Collins; D Crivellari; M F Fey; E Murray; O Pagani; E Simoncini; M Castiglione-Gertsch; R D Gelber; A S Coates; A Goldhirsch
Journal:  Ann Oncol       Date:  2006-04-07       Impact factor: 32.976

9.  Distribution of brain metastases.

Authors:  J Y Delattre; G Krol; H T Thaler; J B Posner
Journal:  Arch Neurol       Date:  1988-07

10.  Brain metastases from solid tumors: disease outcome according to type of treatment and therapeutic resources of the treating center.

Authors:  Alessandra Fabi; Alessandra Felici; Giulio Metro; Alessandra Mirri; Emilio Bria; Stefano Telera; Luca Moscetti; Michelangelo Russillo; Gaetano Lanzetta; Giovanni Mansueto; Andrea Pace; Marta Maschio; Antonello Vidiri; Isabella Sperduti; Francesco Cognetti; Carmine M Carapella
Journal:  J Exp Clin Cancer Res       Date:  2011-01-18
View more
  334 in total

1.  TNF-α enhancement of CD62E mediates adhesion of non-small cell lung cancer cells to brain endothelium via CD15 in lung-brain metastasis.

Authors:  Samah A Jassam; Zaynah Maherally; James R Smith; Keyoumars Ashkan; Federico Roncaroli; Helen L Fillmore; Geoffrey J Pilkington
Journal:  Neuro Oncol       Date:  2015-10-15       Impact factor: 12.300

Review 2.  Pharmacokinetic Properties of Anticancer Agents for the Treatment of Central Nervous System Tumors: Update of the Literature.

Authors:  Megan O Jacus; Vinay M Daryani; K Elaine Harstead; Yogesh T Patel; Stacy L Throm; Clinton F Stewart
Journal:  Clin Pharmacokinet       Date:  2016-03       Impact factor: 6.447

3.  Brain metastases in malignant pleural mesothelioma.

Authors:  Tomoko Yamagishi; Nobukazu Fujimoto; Yosuke Miyamoto; Michiko Asano; Yasuko Fuchimoto; Sae Wada; Kenichi Kitamura; Shinji Ozaki; Hideyuki Nishi; Takumi Kishimoto
Journal:  Clin Exp Metastasis       Date:  2015-11-30       Impact factor: 5.150

4.  Magnetic Resonance-Guided Laser-Induced Thermal Therapy for Recurrent Brain Metastases in the Motor Strip After Stereotactic Radiosurgery.

Authors:  Aditya Iyer; Casey H Halpern; Gerald A Grant; Sayantan Deb; Gordon H Li
Journal:  Cureus       Date:  2016-12-07

5.  Brain metastasis and herniation in a patient with ampullary adenocarcinoma presenting with jaundice and memory loss: case report.

Authors:  Abdullah Saleh ALQattan; Omar Ali Al-Ghamdi; Mumtaz Sarang; Mohammed Saad Al-Qahtani
Journal:  J Gastrointest Oncol       Date:  2018-10

6.  Deep learning enables automatic detection and segmentation of brain metastases on multisequence MRI.

Authors:  Endre Grøvik; Darvin Yi; Michael Iv; Elizabeth Tong; Daniel Rubin; Greg Zaharchuk
Journal:  J Magn Reson Imaging       Date:  2019-05-02       Impact factor: 4.813

7.  Estimating the annual frequency of synchronous brain metastasis in the United States 2010-2013: a population-based study.

Authors:  Courtney Kromer; Jordan Xu; Quinn T Ostrom; Haley Gittleman; Carol Kruchko; Raymond Sawaya; Jill S Barnholtz-Sloan
Journal:  J Neurooncol       Date:  2017-05-31       Impact factor: 4.130

8.  The risk of radiation necrosis following stereotactic radiosurgery with concurrent systemic therapies.

Authors:  Joseph M Kim; Jacob A Miller; Rupesh Kotecha; Roy Xiao; Aditya Juloori; Matthew C Ward; Manmeet S Ahluwalia; Alireza M Mohammadi; David M Peereboom; Erin S Murphy; John H Suh; Gene H Barnett; Michael A Vogelbaum; Lilyana Angelov; Glen H Stevens; Samuel T Chao
Journal:  J Neurooncol       Date:  2017-04-22       Impact factor: 4.130

Review 9.  Tumor bed radiosurgery: an emerging treatment for brain metastases.

Authors:  Mark J Amsbaugh; Warren Boling; Shiao Woo
Journal:  J Neurooncol       Date:  2015-04-25       Impact factor: 4.130

10.  Time-delayed contrast-enhanced MRI improves detection of brain metastases: a prospective validation of diagnostic yield.

Authors:  Or Cohen-Inbar; Zhiyuan Xu; Blair Dodson; Tanvir Rizvi; Christopher R Durst; Sugoto Mukherjee; Jason P Sheehan
Journal:  J Neurooncol       Date:  2016-08-27       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.